Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
December 01, 2012
JTCB. 2012 Dec 1; 10 (3) : 095-101

The Distribution of MEFV Gene Mutations in Patients Pre-Diagnosed as FMF in Izmir Region

1 Sağlık Bakanlığı İzmir Bozyaka Eğitim Araştırma Hastanesi, Biyokimya, İzmir
2 İzmir Üniversitesi Tıp Fakültesi Biyokimya Anabilim Dalı, İzmir

Abstract

Objective: Familial Mediterranean Fever (FMF) is an autosomal recessive genetic disease that primarily affects populations surrounding the Mediterranean basin. The gene linked to FMF, called MEFV, encodes a 781-aa protein called pyrin (Marenostrin). MEFV locates on to the short arm of chromosome 16p (16p13,3). The prevalence reaches a high of 1 in 1000 individuals in the Turkish population; some studies reported the carrier rate in Turkey also to be 15-34 %. We aimed to find the frequency of mutation of MEFV in İzmir Bozyaka Education and Reseach Hospital.

Materials and Methods: The medical records of the patients were evaluated retrospectively. In this study, the most prevalent MEFV gene mutations were analyzed for 656 cases (age range 1-84 yr) referred to our department with the diagnosis of FMF. Twelve common MEFV gene mutations were studied with a reverse hybridization assay as described by the manufacturer.

Results: Of these cases, 342 (42.1%) were identified with an MEFV gene mutation. Among those, 56 patients were found to be homozygote for pyrin mutations; 110 patients were with compound heterozygosity; 176 patients were found to carry only one of the screened mutations.

Conclusion: The allele frequency of FMF mutations in the study groups were M694V % 16.0, E148Q 6.6%, M680I (G/C) 5.5%, V726A 4.1%, P369S 1.6%, A744S 1.5%, R761H 1.2%, M680I (G/A) 0.8%, M694I 0.6%, K695R 0.5%, F479L 0.5%, I692del %0.0.

Citation

Güleç, Derya, Aydan Çelebiler, and Baysal Karaca. 2012. “The Distribution of MEFV Gene Mutations in Patients Pre-Diagnosed As FMF in Izmir Region”. Journal of Turkish Clinical Biochemistry 10 (3):095-101. https://turkclinbiochem.org/index.php/pub/article/view/174.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.